Open Access Open Access  Restricted Access Subscription or Fee Access

Doctor driven problem or doctor driven solution?

Lynn R. Webster, MD, FACPM, FASAM



Full Text:



Lowes R: CDC Issues Opioid Guidelines for ‘Doctor-Driven’ Epidemic. Medscape. May 15, 2016.

Nahin RL: Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769-780.

Institute of Medicine Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US); 2011.

Foreman J: The Global Pain Crisis. Oxford University Press, Incorporated; 2017.

Schatman ME: The role of the health insurance industry in perpetuating suboptimal pain management. Pain Med. 2011; 12(3): 415-426.

Schatman ME: The demise of multidisciplinary pain management clinics? Pract Pain Manag. 2006; 6: 30-41.

American Academy of Pain Medicine: AAPM comments to the CDC on the proposed 2016 guideline for prescribing opioids for chronic pain. January 12, 2016. Available at Accessed November 17, 2017.

Dowell D, Haegerich TM, Chou R: CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep. 2016; 65(1): 1-49.

Washington State Agency Medical Directors’ Group: Interagency Guideline on Prescribing Opioids for Pain, 3rd ed. 2015.

Ziegler SJ: The Proliferation of Dosage Thresholds in Opioid Prescribing Policies and Their Potential to Increase Pain and Opioid-Related Mortality. Pain Med. 2015; 16(10): 1851-1856.

Chou R, Fanciullo GJ, Fine PG, et al.: Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009; 10(2): 131-146.

Department of Veterans Affairs, Department of Defense: VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain. 2017.

Rolfs RT, Johnson E, Williams NJ, et al.: Utah clinical guidelines on prescribing opioids for treatment of pain. J Pain Palliat Care Pharmacother. 2010; 24(3): 219-235.

US Food and Drug Administration: FDA opioids action plan. July 11, 2017. Available at: Accessed November 20, 2017.

US Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Abuse-Deterrent Opioids—Evaluation and Labeling: Guidance for Industry. April 2015. Available at Accessed Novem ber 20, 2017.



  • There are currently no refbacks.
This site uses cookies to maintain session information critical to the user's experience and environment on this system. Click "Accept Cookies" to continue.
For more details please visit our privacy statement at: Privacy & GDPR